Proscillaridin A slows the prostate cancer progression through triggering the activation of endoplasmic reticulum stress

Prostate cancer (PCa) is the second commonly diagnosed malignancy in men over the world. Although androgen deprivation therapy for advanced PCa patients has significantly improved their survival, the majority of these patients eventually develop castration-resistant prostate cancer (CRPC). Proscilla...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Cycle
Autors principals: Wang, Fan, Liu, Lin, Tong, Yu, Li, Linfeng, Liu, Yanfeng, Gao, Wei-Qiang
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7100983/
https://ncbi.nlm.nih.gov/pubmed/32009541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1716484
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars